AT327373B - Verfahren zur herstellung pharmazeutischer zubereitungen - Google Patents

Verfahren zur herstellung pharmazeutischer zubereitungen

Info

Publication number
AT327373B
AT327373B AT1049172A AT1049172A AT327373B AT 327373 B AT327373 B AT 327373B AT 1049172 A AT1049172 A AT 1049172A AT 1049172 A AT1049172 A AT 1049172A AT 327373 B AT327373 B AT 327373B
Authority
AT
Austria
Prior art keywords
manufacturing
pharmaceutical preparations
preparations
pharmaceutical
Prior art date
Application number
AT1049172A
Other languages
German (de)
English (en)
Other versions
ATA1049172A (de
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ATA1049172A publication Critical patent/ATA1049172A/de
Application granted granted Critical
Publication of AT327373B publication Critical patent/AT327373B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT1049172A 1971-12-11 1972-12-11 Verfahren zur herstellung pharmazeutischer zubereitungen AT327373B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161588A DE2161588C3 (de) 1971-12-11 1971-12-11 Mittel zur Behandlung von Hyperlipoproteinämien

Publications (2)

Publication Number Publication Date
ATA1049172A ATA1049172A (de) 1975-04-15
AT327373B true AT327373B (de) 1976-01-26

Family

ID=5827712

Family Applications (1)

Application Number Title Priority Date Filing Date
AT1049172A AT327373B (de) 1971-12-11 1972-12-11 Verfahren zur herstellung pharmazeutischer zubereitungen

Country Status (14)

Country Link
AT (1) AT327373B (xx)
AU (1) AU466300B2 (xx)
BE (1) BE792421A (xx)
BR (1) BR7208624D0 (xx)
CA (1) CA989307A (xx)
DD (1) DD102583A5 (xx)
DE (1) DE2161588C3 (xx)
FR (1) FR2162493B1 (xx)
GB (1) GB1356094A (xx)
HU (1) HU167337B (xx)
IL (1) IL40912A (xx)
MY (1) MY7700129A (xx)
NL (1) NL159579B (xx)
ZA (1) ZA728251B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2502678C3 (de) * 1975-01-23 1981-05-14 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung primärer und sekundärer Hyperlipoproteinämien
DE2621873C3 (de) 1976-05-17 1981-05-07 Ludwig Merckle Kg Chem. Pharm. Fabrik, 7902 Blaubeuren Arzneimittel zur Behandlung von Hypercholesterinämien
FR2430229A1 (fr) * 1978-01-16 1980-02-01 Laruelle Claude Nouvelles compositions pour le traitement des hyperlipoproteinemies et procedes de preparation
US4820739A (en) * 1982-06-28 1989-04-11 Lucta, S.A. Fat suppressant
US4859703A (en) * 1987-06-15 1989-08-22 Warner-Lambert Company Lipid regulating compositions

Also Published As

Publication number Publication date
IL40912A0 (en) 1973-01-30
AU4991872A (en) 1974-06-13
ZA728251B (en) 1973-07-25
CA989307A (en) 1976-05-18
GB1356094A (en) 1974-06-12
NL159579B (nl) 1979-03-15
FR2162493B1 (xx) 1975-06-20
DE2161588A1 (de) 1973-06-20
NL7216788A (xx) 1973-06-13
DE2161588C3 (de) 1980-02-14
BR7208624D0 (pt) 1973-09-20
MY7700129A (en) 1977-12-31
ATA1049172A (de) 1975-04-15
DD102583A5 (xx) 1973-12-20
IL40912A (en) 1975-11-25
DE2161588B2 (de) 1976-05-26
BE792421A (fr) 1973-06-07
FR2162493A1 (xx) 1973-07-20
HU167337B (xx) 1975-09-27
AU466300B2 (en) 1975-10-23

Similar Documents

Publication Publication Date Title
AT326270B (de) Verfahren zur herstellung von arzneiformen
AT287205B (de) Verfahren zur Herstellung von Arzneimittelzubereitungen
AT325201B (de) Verfahren zur herstellung von 7-acylamidocephalosporamsäuren
AT327190B (de) Verfahren zur herstellung von 1-hydroxi-2-pyridonen
AT319259B (de) Verfahren zur Herstellung neuer Dihydropyridazone
AT306228B (de) Verfahren zur Herstellung pharmazeutischer Zubereitungen
AT317428B (de) Verfahren zur Herstellung von Cephalosporin C
AT318920B (de) Verfahren zur Herstellung stabiler Zubereitungen
AT315829B (de) Verfahren zur Herstellung von 4-Halogenmethylcumarinen
AT312803B (de) Verfahren zur Herstellung von 7-Amino-desacetoxy-cephalosporansäure
AT327373B (de) Verfahren zur herstellung pharmazeutischer zubereitungen
AT309679B (de) Verfahren zur Herstellung von 6-Desoxytetracyclinen
ATA1092972A (de) Verfahren zur herstellung von 7-acylamino-3-substituierten-3-cephem-4-carbonsaurederivate
AT324553B (de) Verfahren zur herstellung von 3-alkylthiomethylcephalosporinen
AT320627B (de) Verfahren zur Herstellung von α-Deoxytetracyclinen
AT327910B (de) Verfahren zur herstellung von 5-acyl-iminostilben-derivaten
AT318823B (de) Verfahren zur Herstellung von 16-Carboxy-17-methoxy-eburnan
DD101403A5 (de) Verfahren zur herstellung von phenylimidazolidinonen
AT326816B (de) Verfahren zur herstellung von 3-carbamoyloxymethylcephalosporinverbindungen
AT336009B (de) Verfahren zur herstellung von 2-amino-2-oxazolinen
AT288596B (de) Verfahren zur Herstellung pharmazeutischer Präparate
AT315191B (de) Verfahren zur Herstellung von Arylsulfonylharnstoffen
CH528533A (de) Verfahren zur Herstellung von Thiazylharnstoffen
AT331240B (de) Verfahren zur herstellung von 4-chlor-2-hydroxybenzothiazol
CH530405A (de) Verfahren zur Herstellung von 7-Chlor-benzodiazepin-Derivaten

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee